🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is a single-center, single-arm, prospective phase II clinical st...
Status
Completed
Location
Tianjin Cancer Hospital
Start Date
2021-01-01
Trial ID
NCT04903652
Treatments Being Tested
According to the investigator's judgment, there are concomitant diseases th...
Status
Unknown
Location
Shengjing Hospital of China Medical University
Start Date
2021-09-07
Trial ID
NCT05070598
Treatments Being Tested
To explore the efficacy and safety of pyrotinib combined with docetaxel reg...
Status
Unknown
Location
Zhejiang Cancer Hospital
Start Date
2019-03
Trial ID
NCT03876587
Treatments Being Tested
The purpose of this study is to identify the highest tolerable dose of pyro...
Status
Unknown
Location
Multiple Locations
Start Date
2019-08-15
Trial ID
NCT03997539
Treatments Being Tested
At present, the main characteristics of the enrolled population in the clin...
Status
Unknown
Location
Multiple Locations
Start Date
2022-06-30
Trial ID
NCT05411276
Treatments Being Tested
This is a multicenter, single-arm phase II clinical study to evaluate the s...
Status
Recruiting
Location
Peking Union Medical College
Start Date
2021-12-08
Trial ID
NCT05751018
Treatments Being Tested
To Observe the Efficacy and Safety of Pyrotinib Maleate in Patients With HE...
Status
Unknown
Location
The Second Affiliated hospital of Zhejiang University School of Medical
Start Date
2019-12-17
Trial ID
NCT04380012
Treatments Being Tested
This study will explore the efficacy and safety of tislelizumab (PD1 inhibi...
Status
Unknown
Location
Multiple Locations
Start Date
2022-06-20
Trial ID
NCT05350917
Treatments Being Tested
This study is an open-label, biomarker-integrated umbrella trial designed t...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-07-01
Trial ID
NCT07653451
Treatments Being Tested
Part 1: to assess the safety and tolerability of pyrotinib and to define th...
Status
Unknown
Location
University of California, Irvine School of Medicine
Start Date
2015-06
Trial ID
NCT02500199
Treatments Being Tested